The InvestiGAIT Study

This study is currently not recruiting participants.

This trial aims to determine the efficacy of a new treatment on patient physical function, skeletal muscle mass and strength in older adults with sarcopenia

Benefits to you

  • Free exercise program, vitamin D and protein supplementation
  • Health check-up including blood tests, bone density and body composition assessment
  • Reimbursement for travel may also be available.

Commitment

This study will last up to 28 weeks and is being conducted by Professor Peter R Ebeling AO at Monash Health.  During this time, you would receive a new investigational medication or placebo (dummy treatment) every four weeks for a 6-month period. If you meet the study criteria you will need to attend a study clinic 11 - 13 times so that we can monitor your health and see how you’re responding to the study medication.

Eligibility

  • Are you 70 years of age or older?
  • Are you having difficulty walking, rising from a chair or climbing stairs?

This may be due to a condition called sarcopenia (i.e., age related weakness) and you may be eligible for a research study evaluating a new medicine to treat this condition.

For further enquiries please contact med-bmrg@monash.edu